Glucose Health, Inc. (OTCMKTS:GLUC) Stock Short Interest Report for September

Glucose Health, Inc. (OTCMKTS:GLUC) saw a large growth in short interest in September. As of September 30th, there was short interest totaling 888 shares. Based on an average daily volume of 26,004 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

Glucose Health News Roundup

Here are the key news stories impacting Glucose Health this week:

• Positive Sentiment: Several articles reinforce consumer interest in blood-sugar management, including high-protein snacks, sardines, walking, meal sequencing, and dietary choices such as fruit, pasta sauce, and peanut-butter toast. This broad health focus could support long-term awareness of products positioned around glucose support, although no direct benefit to GLUC’s sales is reported. 9 High-Protein Snacks Dietitians Recommend for Better Blood Sugar Walking This Way May Lower Your Type 2 Diabetes Risk by up to 39%
• Neutral Sentiment: Coverage highlights diabetes education and disease-management resources, including a free community workshop, recommended nutrition resources, and a report that lifestyle changes helped some patients achieve type 2 diabetes remission. These items may increase public attention to the category but do not mention Glucose Health or its products. The 4 Best Nutritional Resources of 2026 for People With Diabetes Free Healthy Living With Diabetes Workshop
• Neutral Sentiment: Other reports examine blood-sugar responses to oranges versus sumo citrus, grapes versus raisins, sourdough, and normal glucose fluctuations, as well as research into biological mechanisms linking liver and pancreas dysfunction. The findings are informational rather than commercial and offer no identifiable near-term catalyst for GLUC. Oranges vs. Sumo Citrus A Little Blood Sugar Fluctuation May Not Be a Bad Thing
• Negative Sentiment: A newly introduced HemaBalance blood-sugar dietary supplement represents additional competition in the broader glucose-support market. The announcement does not indicate any relationship with GLUC, but increased supplement offerings could make customer acquisition more challenging. Hema Balance Blood Optimizer Introduces HemaBalance Capsules

Glucose Health Stock Performance

Shares of Glucose Health stock traded down $0.12 during trading on Wednesday, hitting $0.31. 175 shares of the stock traded hands, compared to its average volume of 21,669. The stock has a market cap of $8.50 million, a P/E ratio of -10.33 and a beta of 1.10. The company has a fifty day moving average price of $0.35 and a two-hundred day moving average price of $0.38. Glucose Health has a twelve month low of $0.02 and a twelve month high of $0.67.

Glucose Health (OTCMKTS:GLUC) last released its earnings results on Friday, August 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.04 million for the quarter.

About Glucose Health

Glucose Health, Inc is a consumer health company focused on developing and marketing nutritional products intended to support healthy blood glucose levels and metabolic wellness. The company’s offerings are positioned as dietary supplements and functional nutrition products rather than prescription medicines.

Its principal product has been GlucoDown, a powdered drink mix marketed for use as part of a daily wellness routine. The product is formulated with nutritional ingredients intended to support blood sugar management, and is sold directly to consumers through online channels.

Publicly available information about Glucose Health’s operating history, geographic reach, and current leadership is limited.